The Truth About A1c

Did you know this truth about HbA1c?

Recent Content

New endocrinology drugs

Since June of 2014, the US FDA has approved a number of drugs for a variety of endocrine-related diseases. Here are 10 of them.

While we are increasingly evaluated on numbers—A1c, blood pressure, LDL—these parameters are largely outside of our direct control. Mr M is a case in point.

There are pros and cons to using SGLT2 inhibitors in the elderly. Are you familiar with both? Find out with 7 quick multiple choice questions.

Cardiovascular disease is the underlying cause of death in more than 60% of patients with T2DM. GLP-1 receptor agonists have shown promising cardioprotective effects.

John is an active older man whose A1c has gone from 6.8% to 7.6% since his last follow-up visit. He refuses to get involved in any “needle business.” What’s next?

Four questions for you to answer, four facts you need to know.

Results of a population-based case-control study point to a general underlying diabetes effect on pancreatitis risk, rather than a specific drug effect.

By clicking Accept, you agree to become a member of the UBM Medica Community.